| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc299202a8b5769ec9c8af124b3ac185 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-40 |
| filingDate |
2002-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b7e5e49315336a22ceb13d59d4ea1f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41b1c6beb9cbf45ac44441bc6e2ab024 |
| publicationDate |
2002-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02060392-A2 |
| titleOfInvention |
Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| abstract |
This invention is directed to pyrimidine and indolone derivatives which are selective antagonists for the GAL3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and apharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's depression and/or anxiety. This invention also provides a method of treating depression and/or anxiety in a subject which comprises administering to the subject a composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a GAL3 receptor antagonist. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004014307-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7220775-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10125144-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8846677-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004034967-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104903312-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11739072-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8344001-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8501739-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004014307-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004034967-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8685972-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8378097-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6936607-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011207733-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005094896-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005094896-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104903312-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7868034-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7893261-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2241316-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03062225-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016237095-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7166635-B2 |
| priorityDate |
2001-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |